Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Qin, Shukui"'
Autor:
Jin Y; Department of Medical Oncology, Sun Yat-Sen University Cancer Centre, Guangzhou, China., Li J; Department of Medical Oncology, Shanghai Oriental Hospital Affiliated Tongji University East Hospital, Shanghai, China., Shen L; Department of Gastrointestinal Oncology, Beijing Cancer Hospital, Beijing, China., Xu J; Department of Medical Oncology, The Fifth Medical Centre of Chinese PLA General Hospital, Beijing, China., Zhang Y; Department of Gastroenterology, Harbin Medical University Cancer Hospital, Harbin, China., Zhang J; Department of Gastroenterology, Liaoning Cancer Hospital and Institute, Shenyang, China., Pan H; Department of Medical Oncology, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, Hangzhou, China., Qu X; Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, China., Chen Y; Department of Medical Oncology, First Affiliated Hospital of Dalian Medical University, Dalian, China., Zhang Q; Eli Lilly and Company, Lilly China Drug Development and Medical Affairs Centre, Shanghai, China., Li J; Eli Lilly and Company, Lilly China Drug Development and Medical Affairs Centre, Shanghai, China., Sun M; Eli Lilly and Company, Lilly China Drug Development and Medical Affairs Centre, Shanghai, China., Qin S; Department of Medical Oncology, People's Liberation Army (PLA) Cancer Centre of Jinling Hospital, Nanjing, China.
Publikováno v:
Frontiers in oncology [Front Oncol] 2022 Nov 24; Vol. 12, pp. 1044328. Date of Electronic Publication: 2022 Nov 24 (Print Publication: 2022).
Autor:
Zhang Y; Department of Graduate School, Nanjing University of Chinese Medicine, Nanjing, China., Qin S; Department of Medical Oncology Center, BaYi Affiliated Hospital, Nanjing, China., Chao J; Department of Graduate School, Nanjing University of Chinese Medicine, Nanjing, China., Luo Y; Department of Biochemistry and Cancer Institute of the Second Affiliated Hospital (Key Laboratory of Cancer Prevention and Intervention of China National Ministry of Education (MOE)), Zhejiang University School of Medicine, Hangzhou, China., Sun Y; Department of Biochemistry and Cancer Institute of the Second Affiliated Hospital (Key Laboratory of Cancer Prevention and Intervention of China National Ministry of Education (MOE)), Zhejiang University School of Medicine, Hangzhou, China., Duan J; Ascentawits Pharmaceuticals, Ltd., Shenzhen, China.
Publikováno v:
Frontiers in oncology [Front Oncol] 2022 Jul 22; Vol. 12, pp. 885139. Date of Electronic Publication: 2022 Jul 22 (Print Publication: 2022).
Autor:
Zheng X; Nanjing University of Chinese Medicine, Nanjing, China.; Oncology Department, Jiangsu Province Hospital of Chinese Medicine, Nanjing, China., Gou Y; Nanjing University of Chinese Medicine, Nanjing, China., Jiang Z; Nanjing University of Chinese Medicine, Nanjing, China.; Oncology Department, Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, China., Yang A; Laboratory Department, Nanjing Jinling Hospital, Nanjing, China., Yang Z; Pathology Department, Nanjing Jinling Hospital, Nanjing, China., Qin S; Nanjing University of Chinese Medicine, Nanjing, China.; Oncology Department, Nanjing Jinling Hospital, Nanjing, China.
Publikováno v:
Frontiers in oncology [Front Oncol] 2021 Oct 26; Vol. 11, pp. 740557. Date of Electronic Publication: 2021 Oct 26 (Print Publication: 2021).
Autor:
Ma J; Department of Urology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Song Y; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Shou J; Department of Urology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Bai Y; Department of Gastrointestinal Oncology, Harbin Medical University Cancer Hospital, Harbin, China., Li H; Department of Urology, Peking Union Medical College Hospital, Beijing, China., Xie X; Department of Oncology, General Hospital of Northern Theater Command, Shenyang, China., Luo H; Department of Urology and Oncology, Chongqing University Cancer Hospital, Chongqing Cancer Hospital, Chongqing, China., Ren X; Department of Biotherapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer/Key Laboratory of Cancer Prevention and Therapy, Tianjin/Tianjin's Clinical Research Center for Cancer, Tianjin, China., Liu J; Department of Biotherapy, Cancer Center, West China Hospital, Sichuan University, Chengdu, China., Ye D; Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China., Bai X; Department of Urinary Surgery, Guangxi Medical University Affiliated Tumor Hospital, Nanning, China., Fu C; Department of Urology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Shenyang, China., Qin S; Cancer Center, Jinling Hospital, Nanjing, China., Wang J; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Zhou AP; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Publikováno v:
Frontiers in oncology [Front Oncol] 2020 May 07; Vol. 10, pp. 664. Date of Electronic Publication: 2020 May 07 (Print Publication: 2020).